![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 Dr. Reddy\'s Laboratories (2)
02 Accure Labs (2)
03 Apotex Inc (1)
04 Assia Chemical Industries Ltd (1)
05 Bluepharma (2)
06 Intas Pharmaceuticals (2)
07 Laboratorio Eczane Pharma (2)
08 Novartis Pharmaceuticals Australia Pty Limited (12)
09 Novartis Pharmaceuticals Corporation (3)
10 Novartis South Africa (Pty) Ltd (2)
11 Novugen (1)
12 Pharmacare Premium (1)
13 Pharmascience Inc. (1)
14 Pluviaendo (2)
15 Sakar Healthcare (2)
16 Sun Pharmaceutical Industries Limited (1)
17 TherDose Pharma (2)
18 Torrent Pharmaceuticals Limited (2)
01 FCT (2)
02 Film Coated Tablet (6)
03 Oral Solid Dosage Form (2)
04 TABLET (4)
05 TABLET;ORAL (6)
06 Tablet (4)
07 Tablets (4)
08 Blank (13)
01 DISCN (1)
02 Generic (2)
03 Lead Market Dossiers- Under Development (2)
04 Originator (2)
05 Prescription (2)
06 RX (5)
07 Blank (27)
01 PAZOPANIB HYDROCHLORIDE (4)
02 PMS-PAZOPANIB (1)
03 Pazopane (2)
04 VOTRIENT (3)
05 Votrient (12)
06 Votrient 200 mg (1)
07 Votrient 400 mg (1)
08 Blank (17)
01 Argentina (2)
02 Australia (12)
03 Canada (2)
04 India (12)
05 Malta (1)
06 Portugal (2)
07 South Africa (2)
08 Turkey (2)
09 USA (6)